|
Research & Development
|
| | 38.44M | 18.94M | | |
|
Selling, General & Administrative
|
| | 13.00M | 15.33M | | |
|
Other Operating Expenses
|
| | | 35.00M | | |
|
Operating Expenses
|
| | 51.44M | 34.27M | | |
|
Operating Income
|
| | -51.44M | 0.73M | | |
|
EBIT
|
| | -51.44M | 0.73M | | |
|
Interest & Investment Income
|
| | 0.23M | 0.94M | | |
|
Other Non Operating Income
|
| | -0.17M | -0.10M | | |
|
Non Operating Income
|
| | -0.17M | 0.85M | | |
|
EBT
|
| | -51.38M | 1.58M | | |
|
Tax Provisions
|
| | | 0.09M | | |
|
Profit After Tax
|
| | -51.38M | 1.49M | | |
|
Income from Continuing Operations
|
| | -51.38M | 1.49M | | |
|
Consolidated Net Income
|
| | -51.38M | 1.49M | | |
|
Income towards Parent Company
|
| | -51.38M | 1.49M | | |
|
Net Income towards Common Stockholders
|
| | -51.38M | 1.49M | | |
|
EPS (Basic)
|
| | -0.00M | 0.00M | | |
|
EPS (Weighted Average and Diluted)
|
| | -0.00M | 0.00M | | |
|
Shares Outstanding (Weighted Average)
|
4.08M | 4.35M | 6.57M | 6.57M | 41.21M | 48.86M |
|
EBITDA
|
| | -51.40M | 1.50M | | |
|
Tax Rate
|
| | | 5.58% | | |